Clinical Trials Arena on MSN
AiCuris reports positive Phase III pritelivir results for HSV patients
The trial enrolled and treated 101 immunocompromised patients with refractory or resistant HSV infection.
Herpes is one of the most common viral infections in the world, yet it remains widely misunderstood. Caused by the herpes ...
A new study in "Nature Medicine" estimates 2 million people are incorrectly told they have TB each year — and clinicians miss ...
We go to school, study further, then learn new things in our chosen careers. But no matter how much knowledge we acquire, ...
New kits let people bypass the doctor and order a range of diagnostic tests. Is this a good idea?
Researchers examined the incidence of hepatitis B reactivation and incident infection after switching to long-acting cabotegravir plus rilpivirine among patients with HIV.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results